Skip to content
10-Q

Quarterly Report

ROCKWELL MEDICAL, INC. RMTI

0001628280-26-031663

← back to feed
Filed
May 7, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2026 · Apr 30, 2026 39.47M sh
Shares Diluted Q1 2026 · Mar 31, 2026 39.42M sh
Shares Diluted Q1 2026 · Mar 31, 2025 34.11M sh
Capex Q1 2026 · Mar 31, 2026 $425K
Capex Q1 2026 · Mar 31, 2025 $63K
Operating Cash Flow Q1 2026 · Mar 31, 2026 −$167K
Operating Cash Flow Q1 2026 · Mar 31, 2025 −$3.49M
Long Term Debt Q1 2026 · Mar 31, 2026 $8.21M
Long Term Debt Q1 2026 · Dec 31, 2025 $8.83M
Short Term Debt Q1 2026 · Mar 31, 2026 $707K
Short Term Debt Q1 2026 · Dec 31, 2025 $0
Cash And Equivalents Q1 2026 · Mar 31, 2026 $9.61M
Cash And Equivalents Q1 2026 · Dec 31, 2025 $10.71M
Stockholders Equity Q1 2026 · Mar 31, 2026 $35.86M
Stockholders Equity Q1 2026 · Dec 31, 2025 $36.98M
Stockholders Equity Q1 2026 · Mar 31, 2025 $31.52M
Stockholders Equity Q1 2026 · Dec 31, 2024 $32.59M
Current Liabilities Q1 2026 · Mar 31, 2026 $9.87M
Current Liabilities Q1 2026 · Dec 31, 2025 $9.58M
Total Liabilities Q1 2026 · Mar 31, 2026 $21.57M
Total Liabilities Q1 2026 · Dec 31, 2025 $20.16M
Current Assets Q1 2026 · Mar 31, 2026 $36.94M
Current Assets Q1 2026 · Dec 31, 2025 $38.16M
Total Assets Q1 2026 · Mar 31, 2026 $57.42M
Total Assets Q1 2026 · Dec 31, 2025 $57.15M
Eps Diluted Q1 2026 · Mar 31, 2026 −$0.04
Eps Diluted Q1 2026 · Mar 31, 2025 −$0.04
Eps Basic Q1 2026 · Mar 31, 2026 −$0.04
Eps Basic Q1 2026 · Mar 31, 2025 −$0.04
Net Income Q1 2026 · Mar 31, 2026 −$1.61M
Net Income Q1 2026 · Mar 31, 2025 −$1.52M
Operating Income Q1 2026 · Mar 31, 2026 −$1.48M
Operating Income Q1 2026 · Mar 31, 2025 −$1.36M
Gross Profit Q1 2026 · Mar 31, 2026 $2.9M
Gross Profit Q1 2026 · Mar 31, 2025 $3.04M
Cost Of Revenue Q1 2026 · Mar 31, 2026 $14.44M
Cost Of Revenue Q1 2026 · Mar 31, 2025 $15.87M
Revenue Q1 2026 · Mar 31, 2026 $17.34M
Revenue Q1 2026 · Mar 31, 2025 $18.91M